Heln hrar alpha cell line

HELN were generated by transfection of cervical cancer HeLa cells with the ERE-betaGlobin-Luciferase-SV40-Neomycin plasmid. HELN hRAR alpha cells were generated by transfection of HELN cells with the pSG5-puro plasmid pSG5-human RAR alpha (ER alpha DBD)-puromycin. The plasmid ERE-betaGlob-Luc-SVNeo contains a luciferase gene driven by estrogen receptor responsive element (ERE) in front of beta-globin promoter and a neomycin phosphotransferase gene under the control of SV40 promoter. The pSG5-puro plasmid pSG5-human RAR alpha (ER alpha DBD)-puromycin enables to express the human retinoid receptor alpha in which the DNA binding domain (DBD) has been replaced by the estrogen receptor alpha DBD.

Interest / Relevance: These cells enable to measure the hRAR alpha activity (full and partial agonism, antagonism) of pharmaceuticals (breast cancer, menopause treatment), environmental compounds (alkylphenols, bisphenol A, phthalates or pesticides, cosmetics).
These cells enable to measure the hRAR alpha activity of environmental (water, sediments), human (blood, urine adipose tissue) or food (water, vegetables, meat) samples.

TTNPB EC50 0.8 nM
Keywords: hRAR alpha, luciferase, natural, pharmaceutical and environmental retinoids
Scientist's name: Patrick BALAGUER
Patrick Balaguer

You might also be interested in

Contact

Inserm Transfert

Research tool licensing team

researchtools@inserm-transfert.fr